Related Experiment Video

Updated: Apr 5, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

23.5K

Immune-mediated and lipid-mediated platelet function in atherosclerosis

Maiwand Ahmadsei1, Dirk Lievens, Christian Weber

  • 1aInstitute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-University Munich, Munich, Germany bDZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

Current Opinion in Lipidology
|August 14, 2015
PubMed

Insights

Platelets modulate immune responses in atherosclerosis, influencing lipid metabolism and disease progression. Understanding these roles offers new diagnostic and therapeutic targets for cardiovascular disease.

Area of Science:

  • Immunology
  • Cardiovascular Research
  • Molecular Biology

Background:

  • Cardiovascular disease (CVD) is a leading global health concern, with atherosclerosis as its primary driver.
  • Platelets, beyond hemostasis, play significant roles in inflammatory processes underlying atherosclerosis.
  • Advances in molecular biology are revealing the intricate mechanisms of atherosclerosis.

Purpose of the Study:

  • To outline the role of platelets in modulating immune responses within the context of atherosclerosis.
  • To review interactions between platelets, endothelial cells, and immune cells during atherogenesis.
  • To explore the relationship between platelets and lipid metabolism in atherosclerosis.

Main Methods:

  • Review of current literature on platelet function in atherosclerosis.
  • Discussion of exemplary pathways, such as the CD40/CD40L dyad.
  • Focus on platelet interactions with immune cells and lipid metabolism.

Main Results:

  • Platelets actively modulate immune responses and inflammation in atherosclerosis.
  • Platelet interactions with endothelial and immune cells are crucial in atherogenesis.
  • Platelet involvement in lipid metabolism has significant implications for atherosclerosis and dyslipidemia.

Conclusions:

  • Understanding platelet-related immune activity can lead to novel diagnostic tools and therapeutic strategies for CVD.
  • Targeting platelet functions may offer new drug classes to complement or replace traditional anticoagulants.
  • Enhanced knowledge of platelet mechanisms can improve the clinical management of cardiovascular disease.
Abstract

More Related Videos

Microfluidics in Assessing Platelet Function06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.8K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

1.3K

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.0K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
994
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
589
Inflammation01:38

Inflammation

Overview
64.6K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
635